Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Research Council grant · Finished

PROCT Prostate Diagnosis using Optical Coherence Tomography

Coordinator
Universita Degli Studi Di Verona, Italy
Runs
1 October 2022 to 30 September 2024
Status
Finished
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101069279

What the project is doing

In the project's own words, from its summary on CORDIS.

With 1.3 million new cases worldwide, prostate cancer (PC) is the second most common cancer in men, causing more than 350,000 deaths each year. It is so common that about 1 man in 8 will be diagnosed with prostate cancer during his lifetime. As for any degenerative disease, early diagnosis is crucial to improve patients’ quality of life and reduce the mortality rate. However, the gold standard technique (biopsy) is affected by large diagnostic errors, representing a major limitation to achieve adequate management of PC.The PROCT project aims to validate in pre-clinical stage a semiautonomous robotic approach to PC diagnosis based on Optical Coherence Tomography (OCT), which aims to exactly pinpoint the target lesion and analyse it through an AI and robotic-based imaging setup.

This can comprehensively visualize the lesions at the microscopic level in vivo, without taking any physical sample of the prostate. The resulting virtual microscope slide will allow urologists to explore and analyse various suspicious areas in the same procedure without the need to rely on the physical examination of the biopsy samples. PROCT is a paradigm shift in PC biopsy, that is poised to turn a subjective and operator-dependent procedure into a safer and more accurate diagnostic tool.

This solution is obtained by merging the AI-based target identification with robotic pointing developed in the previous PoC project PROST with a micro-optical coherence tomography sensor capable to acquire images of the prostate through a needle at cellular-level resolution. The PROCT prototype will be laboratory validated and benchmarked to assess its usability and real time capabilities. It will be also tested and validated on ex-vivo animal tissues and in the cadaver laboratory.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di VeronaVeronaItalyCoordinator
Day One Societa a Responsabilita LimitataRoma RmItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI